Zacks Investment Research on MSN
Halozyme's Q4 earnings miss, higher royalties drive Y/Y revenues
Halozyme Therapeutics HALO reported fourth-quarter 2025 adjusted loss of 24 cents per share against the Zacks Consensus Estimate of earnings of $2.15. The company had reported adjusted earnings of $1.
Apple (AAPL) rated Sell: overvaluation, slowing innovation, iPhone dependence, a weak AI strategy, and Vision Pro flop. Read here for more analysis.
Palou's ad, titled "Indy Speed," shows the four-time IndyCar champ checking out milk at a grocery store. The commercial ends with a montage of Palou winning last year's Indy 500 and drinking milk at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results